JD Health International Inc. (JDHIF) Stock Price & Analysis
JD Health International Inc. (JDHIF) — price $4.38 (0.00%), as of the Oct 5, 2026 trading session; market cap $14.0B. Expected results Mar 29, 2027.
Educational signal · not a buy or sell recommendation · How to read this
JD Health International Inc. · JDHIF · Healthcare · Medical - Pharmaceuticals
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $4.38 | |
| Change on the day | 0.00% | |
| 52-week range | $4.38–$8.75 | |
| Market capitalisation | $14.0B | |
| Price / earnings (trailing) | 15.38 | |
| Shares traded on the day | 1.0K | |
| Beta (volatility vs the S&P 500) | 1.18 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results
- · Earnings results · below the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
The provider's estimated date can change.
What to watch nextOther perspectives
Council score for JD Health International (JDHIF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 28, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 6, 2026, except a card that shows its own read date.
Watch the JDHIF film — every key number, told as a short cinematic story
~2 min · open the film
What is JD Health International (JDHIF), and what does it report?
Short answer · as of
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. Healthcare / Medical Pharmaceuticals Headquarters: Jingdong Headquarters, Beijing, BE, 101111, CN. It employs 5,263 people and is led by Dong Cao. In Q2 FY2026 it reported revenue of $6.02B and net income of $506M. The market values it at $14.0B.
What do the latest results show for JD Health International (JDHIF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $6.02B. Against analyst estimates the company has EPS beat 3 of 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $6.02B Aug 13, 2026
- Latest report · revenue estimate
- $6.08B Aug 13, 2026
- Latest report · revenue vs estimate
- Below estimate Aug 13, 2026
- Latest report · EPS vs estimate
- Below estimate Aug 13, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Aug 13, 2026 | $6.02B | $6.08B | $0.1575 | $0.1722 |
| Mar 5, 2026 | $5.45B | $5.34B | $0.1337 | Not available |
| Aug 14, 2025 | $4.92B | $4.73B | $0.1130 | $0.1437 |
| Mar 5, 2025 | $4.08B | $4.05B | $0.0931 | $0.0863 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $6.02B | $506M | $0.16 (diluted) |
| Q4 FY2025 | $5.60B | $408M | $0.13 (diluted) |
| Q2 FY2025 | $5.26B | $387M | $0.12 (diluted) |
| Q4 FY2024 | $4.45B | $317M | $0.10 (diluted) |
What are the financial strengths and risks for JD Health International (JDHIF)?
Short answer
The distress and quality screens read Altman Z 4.89 · Piotroski F 6. Trailing ratios: ROE 9.1% · ROA 6.6% · current ratio 2.72 · earnings yield 5.9% · free-cash-flow yield 11.1%.
What should you watch next at JD Health International (JDHIF)?
Short answer · as of
The next earnings report is expected on Mar 29, 2027.
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
JD Health International Healthcare Stock: Key Questions Answered
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
How does JD Health make money beyond selling medicines?
JD Health monetizes consultations, referrals, home care, health checks, advertising, technical services, digital health solutions and marketplace activity. Medical devices, offline clinics and payment support extend the platform beyond online pharmacy transactions.
What is the JDHIF stock price today?
The last price recorded on this page for JD Health International Inc. (JDHIF) is $4.38, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (38 figures)
The 38 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 32 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $4.38 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T13:44:41.769Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $14.0B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-05T13:44:36.588Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
earn.next | Next earnings date | Mar 29, 2027 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
id.business_summary | Business description (FMP excerpt) | JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. | FMP | Financial Modeling Prep (FMP) company profile — Deterministic excerpt derived from id.description; source and date describe the input fact, not a new provider observation | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
px.range52 | 52-week range | $4.38–$8.75 | FMP | Financial Modeling Prep (FMP) quote | |
px.pe | Price / earnings (trailing) | 15.38 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 1.0K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 1.18 | FMP | Financial Modeling Prep (FMP) company profile | |
id.sector | Sector / industry (provider taxonomy) | Healthcare / Medical Pharmaceuticals | FMP | Financial Modeling Prep (FMP) company profile | |
id.hq | Headquarters | Jingdong Headquarters, Beijing, BE, 101111, CN | FMP | Financial Modeling Prep (FMP) company profile | |
id.employees | Employees | 5,263 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Dong Cao | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
fin.q_revenue | Revenue, Q2 FY2026 | $6.02B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | $506M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
earn.history.depth.2026-08-13.revenue_actual | Revenue · reported — report date 2026-08-13 | $6.02B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-13.revenue_estimated | Revenue · estimate — report date 2026-08-13 | $6.08B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-13.eps_actual | EPS · reported — report date 2026-08-13 | $0.1575 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-13.eps_estimated | EPS · estimate — report date 2026-08-13 | $0.1722 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.revenue_actual | Revenue · reported — report date 2026-03-05 | $5.45B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.revenue_estimated | Revenue · estimate — report date 2026-03-05 | $5.34B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-05.eps_actual | EPS · reported — report date 2026-03-05 | $0.1337 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-08-14.revenue_actual | Revenue · reported — report date 2025-08-14 | $4.92B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-08-14.revenue_estimated | Revenue · estimate — report date 2025-08-14 | $4.73B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-08-14.eps_actual | EPS · reported — report date 2025-08-14 | $0.1130 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-08-14.eps_estimated | EPS · estimate — report date 2025-08-14 | $0.1437 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-05.revenue_actual | Revenue · reported — report date 2025-03-05 | $4.08B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-05.revenue_estimated | Revenue · estimate — report date 2025-03-05 | $4.05B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-05.eps_actual | EPS · reported — report date 2025-03-05 | $0.0931 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-03-05.eps_estimated | EPS · estimate — report date 2025-03-05 | $0.0863 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 3 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-02 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 4.89 · Piotroski F 6 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-05 | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 9.1% · ROA 6.6% · current ratio 2.72 · earnings yield 5.9% · free-cash-flow yield 11.1% | — | UNRECORDED | Stored key metrics — Date unknown |
COMPUTED — 2 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history.depth.2026-08-13.revenue_actual.comparison | Latest report · revenue vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($6.02B) with the recorded estimate ($6.08B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-08-13.eps_actual.comparison | Latest report · EPS vs estimate | Below estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.1575) with the recorded estimate ($0.1722) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 1 fact from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
gap.statement_currency | Statement currency limitation | Detailed statement figures are not shown because their conversion to USD has not been verified. | OURS | Stock Expert AI currency-basis check |
Fact-family notes
- Earnings-history note. Source series as of 2026-08-13. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-08-13.revenue_actual,earn.history.depth.2026-08-13.revenue_estimated,earn.history.depth.2026-08-13.revenue_actual.comparison,earn.history.depth.2026-08-13.eps_actual.comparison,earn.history.depth.2026-08-13.eps_actual,earn.history.depth.2026-08-13.eps_estimated,earn.history.depth.2026-03-05.revenue_actual,earn.history.depth.2026-03-05.revenue_estimated,earn.history.depth.2026-03-05.eps_actual,earn.history.depth.2025-08-14.revenue_actual,earn.history.depth.2025-08-14.revenue_estimated,earn.history.depth.2025-08-14.eps_actual,earn.history.depth.2025-08-14.eps_estimated,earn.history.depth.2025-03-05.revenue_actual,earn.history.depth.2025-03-05.revenue_estimated,earn.history.depth.2025-03-05.eps_actual,earn.history.depth.2025-03-05.eps_estimated.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
Data provided for informational purposes only.